Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.
Human visceral leishmaniasis (VL) is a severe and potentially fatal parasitic disease if not correctly diagnosed and treated. Brazil is one of the three countries most endemic for VL and, like most countries affected by this disease, has a large budget constraint for the incorporation of new health...
Main Authors: | Mariana Lourenço Freire, Aline de Souza, Gláucia Cota, Ana Rabello, Tália Machado de Assis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008741 |
Similar Items
-
Serology for visceral leishmaniasis: How trusty is the accuracy reported by the manufacturers?
by: Mariana Lourenço Freire, et al.
Published: (2023-02-01) -
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis.
by: Mariana Lourenço Freire, et al.
Published: (2019-07-01) -
Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil
by: Tália Santana Machado de Assis, et al.
Published: (2019-04-01) -
The direct costs of treating human visceral leishmaniasis in Brazil
by: Tália Santana Machado de Assis, et al. -
Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil
by: Tália Santana Machado de Assis, et al.
Published: (2017-12-01)